Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:I-152-I-158
doi: 10.1161/CIRCULATIONAHA.105.001123
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mol, A.
Right arrow Articles by Hoerstrup, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mol, A.
Right arrow Articles by Hoerstrup, S. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow CV surgery: valvular disease

(Circulation. 2006;114:I-152 – I-158.)
© 2006 American Heart Association, Inc.


Cell Transplantation and Tissue Engineering

Autologous Human Tissue-Engineered Heart Valves

Prospects for Systemic Application

Anita Mol, PhD; Marcel C.M. Rutten, PhD; Niels J.B. Driessen, MSc; Carlijn V.C. Bouten, PhD; Gregor Zünd, MD; Frank P.T. Baaijens, PhD; Simon P. Hoerstrup, MD, PhD

From the Clinic for Cardiovascular Surgery (A.M., G.Z., S.P.H.), University Hospital Zürich, Zürich, Switzerland; Department of Biomedical Engineering (A.M., M.C.M.R., N.J.B.D., C.V.C.B., F.P.T.B., S.P.H.), Eindhoven University of Technology, the Netherlands.

Correspondence to Anita Mol, Eindhoven University of Technology, Department of Biomedical Engineering, Den Dolech 2/P.O. Box 513, 5600 MB Eindhoven, the Netherlands. E-mail a.mol{at}tue.nl

Background— Tissue engineering represents a promising approach for the development of living heart valve replacements. In vivo animal studies of tissue-engineered autologous heart valves have focused on pulmonary valve replacements, leaving the challenge to tissue engineer heart valves suitable for systemic application using human cells.

Methods and Results— Tissue-engineered human heart valves were analyzed up to 4 weeks and conditioning using bioreactors was compared with static culturing. Tissue formation and mechanical properties increased with time and when using conditioning. Organization of the tissue, in terms of anisotropic properties, increased when conditioning was dynamic in nature. Exposure of the valves to physiological aortic valve flow demonstrated proper opening motion. Closure dynamics were suboptimal, most likely caused by the lower degree of anisotropy when compared with native aortic valve leaflets.

Conclusions— This study presents autologous tissue-engineered heart valves based on human saphenous vein cells and a rapid degrading synthetic scaffold. Tissue properties and mechanical behavior might allow for use as living aortic valve replacements.


Key Words: cells • collagen • mechanics • valves




This article has been cited by other articles:


Home page
CirculationHome page
A. Balguid, A. Mol, M. A.A. van Vlimmeren, F. P.T. Baaijens, and C. V.C. Bouten
Hypoxia Induces Near-Native Mechanical Properties in Engineered Heart Valve Tissue
Circulation, January 20, 2009; 119(2): 290 - 297.
[Abstract] [Full Text] [PDF]